Erica De Candia
Overview
Explore the profile of Erica De Candia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
863
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Agosti P, Kouraki A, Dionisi T, Addolorato G, DInnocenzo L, Sorrentino S, et al.
Arterioscler Thromb Vasc Biol
. 2024 Oct;
44(12):2659-2661.
PMID: 39479767
No abstract available.
2.
Petito E, Bury L, Antunes Heck L, Sadler B, De Candia E, Podda G, et al.
Br J Haematol
. 2024 Oct;
206(1):290-295.
PMID: 39462764
No risk factors have been identified for vaccine-induced immune thrombotic thrombocytopenia (VITT) so far. The aim of this study was to identify human leucocyte antigen (HLA) alleles potentially associated with...
3.
Buonsenso D, Sorrentino S, Ferretti A, Morello R, Valentini P, Di Gennaro L, et al.
Pediatr Infect Dis J
. 2024 Jul;
PMID: 39018475
We investigated if children with Long Covid (n=14) have activated platelets compared with healthy controls (n=14). Platelet activation and secretion markers were investigated by flow cytometry using MoAbs directed against...
4.
Talerico R, Brando E, Luzi L, Vedovati M, Giustozzi M, Verso M, et al.
Intern Emerg Med
. 2024 Jun;
19(6):1645-1652.
PMID: 38943034
It is still uncertain whether direct oral anticoagulants (DOACs) perform better than vitamin K antagonists (VKAs) in subjects with non-valvular atrial fibrillation (NVAF) and advanced chronic kidney disease (CKD). The...
5.
Gallo A, Lipari A, Di Francesco S, Ianua E, Liperoti R, Cipriani M, et al.
Int J Mol Sci
. 2024 Jun;
25(12).
PMID: 38927999
Platelets have a fundamental role in mediating hemostasis and thrombosis. However, more recently, a new idea is making headway, highlighting the importance of platelets as significant actors in modulating immune...
6.
Palareti G, Testa S, Legnani C, Dellanoce C, Cini M, Paoletti O, et al.
Blood Adv
. 2024 Jun;
8(18):4913-4923.
PMID: 38842448
Treatment with direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) is effective and safe. However, bleeding complications still occur. Whether DOAC level measurement may further improve treatment efficacy...
7.
Testa S, Palareti G, Legnani C, Dellanoce C, Cini M, Paoletti O, et al.
Blood Adv
. 2024 Feb;
8(8):1846-1856.
PMID: 38394387
Although effective and safe, treatment with direct oral anticoagulants (DOAC) in atrial fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of DOAC levels may improve treatment efficacy...
8.
Gresele P, Falcinelli E, Bury L, Alessi M, Guglielmini G, Falaise C, et al.
Res Pract Thromb Haemost
. 2024 Jan;
8(1):102305.
PMID: 38292347
Background: In hemophilia and von Willebrand disease, the degree of alteration of laboratory assays correlates with bleeding manifestations. Few studies have assessed the predictive value for bleeding of laboratory assays...
9.
Brambilla M, Becchetti A, Rovati G, Cosentino N, Conti M, Canzano P, et al.
Arterioscler Thromb Vasc Biol
. 2023 Aug;
43(10):2042-2057.
PMID: 37589138
Background: ADP-induced platelet activation leads to cell surface expression of several proteins, including TF (tissue factor). The role of ADP receptors in platelet TF modulation is still unknown. We aimed...
10.
Lipari A, Sorrentino S, Tamburini C, Castaman G, Prisco D, De Candia E
Intern Emerg Med
. 2023 May;
18(4):1233-1238.
PMID: 37165299
No abstract available.